{"doi":"10.1172/jci.insight.187073","title":"Loss of GATA2 promotes invasion and predicts cancer recurrence and survival in uterine serous carcinoma","abstract":"BACKGROUNDA priori knowledge of recurrence risk in patients with nonmetastatic (International Federation of Gynecology and Obstetrics [FIGO] stage I) uterine serous carcinoma (USC) would enable a risk-stratified approach to the use of adjuvant chemotherapy. This would greatly reduce treatment-related morbidity and be predicted to improve survival.METHODSGATA2 expression was scored by IHC across a retrospective multiinstitutional cohort of 195 primary USCs. Associations between GATA2 levels and clinicopathologic metrics were evaluated using Student's t test, Fisher's exact test, Kaplan-Meier method, and Cox proportional hazard ratio. Invasion in patient-derived USC cells was assessed by Student's t test. RNA-Seq, anti-GATA2 ChIP-Seq, and confirmatory Western blotting enabled identification of GATA2 targets.RESULTSPatients with FIGO stage I GATA2hi USCs had 100% recurrence-free and 100% cancer-related survival, which was significantly better than patients with GATA2lo USCs. In patients for whom adjuvant chemotherapy was omitted, patients with GATA2hi USC had 100% recurrence-free 5-year survival compared with 60% recurrence-free survival in patients with GATA2lo USC. Depletion of GATA2 in patient-derived USC cells increased invasion in vitro.CONCLUSIONRoutine GATA2 IHC identifies 33% of patients with FIGO stage I USC who have a greatly reduced risk of posthysterectomy USC recurrence. Our results suggest that a GATA2-guided personalized medicine approach could be rapidly implemented in most hospital settings, would reduce treatment-related morbidity, and would likely improve outcomes in patients with USC.FUNDINGNIH grants R01 DK068634, P30 CA014520, S10 OD023526, K08 DK127244, T32 HL007899, the UW-Madison Department of Pathology and Laboratory Medicine, the UW-Madison Centennial Scholars Program, the Diane Lindstrom Foundation, the American Cancer Society, the V Foundation, The Hartwell Foundation, and the UMN Department of Obstetrics, Gynecology, and Women's Health.","journal":"JCI Insight","year":2025,"id":543579,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9634,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1433603,"name":"Trey E Gilpin","orcid":null,"position":1,"is_corresponding":false},{"id":1120038,"name":"Apoorva T. Patil","orcid":"0000-0002-6339-0419","position":2,"is_corresponding":false},{"id":681170,"name":"Emily Chiu","orcid":null,"position":3,"is_corresponding":false},{"id":1433163,"name":"R. W. R. Baker","orcid":"0000-0002-8546-1804","position":4,"is_corresponding":false},{"id":1433164,"name":"Peng Liu","orcid":"0000-0003-1749-6455","position":5,"is_corresponding":false},{"id":883645,"name":"Tatiana S. Pavletich","orcid":"0000-0002-8813-2125","position":6,"is_corresponding":false},{"id":1433165,"name":"Morteza Seifi","orcid":"0000-0001-5884-9427","position":7,"is_corresponding":false},{"id":1433604,"name":"Paula M. Mañán-Mejías","orcid":null,"position":8,"is_corresponding":false},{"id":1433605,"name":"Jordan Morrissey","orcid":null,"position":9,"is_corresponding":false},{"id":280232,"name":"Jenna Port","orcid":null,"position":10,"is_corresponding":false},{"id":1433606,"name":"Rene Welch Schwartz","orcid":null,"position":11,"is_corresponding":false},{"id":298238,"name":"Irene M. Ong","orcid":"0000-0002-9353-6941","position":12,"is_corresponding":false},{"id":1433166,"name":"Dina El‐Rayes","orcid":"0009-0004-7447-6340","position":13,"is_corresponding":false},{"id":1433167,"name":"Mahmoud A. Khalifa","orcid":"0000-0001-7704-1722","position":14,"is_corresponding":false},{"id":316314,"name":"Pei Hui","orcid":null,"position":15,"is_corresponding":false},{"id":783293,"name":"Vanessa L. Horner","orcid":null,"position":16,"is_corresponding":false},{"id":282371,"name":"Marı́a Virumbrales-Muñoz","orcid":"0000-0003-3660-8651","position":17,"is_corresponding":false},{"id":292552,"name":"Britt Erickson﻿","orcid":"0000-0001-5221-5538","position":18,"is_corresponding":false},{"id":241552,"name":"Lisa Barroilhet","orcid":"0000-0001-9315-2414","position":19,"is_corresponding":false},{"id":262139,"name":"Stephanie M. McGregor","orcid":"0000-0002-7940-1143","position":20,"is_corresponding":false},{"id":333666,"name":"Emery H. Bresnick","orcid":"0000-0002-1151-5654","position":21,"is_corresponding":false},{"id":669557,"name":"Daniel R. Matson","orcid":"0000-0003-1430-3128","position":22,"is_corresponding":false},{"id":1120480,"name":"Usha S. Polaki","orcid":null,"position":0,"is_corresponding":true}],"reference_count":42,"raw_metadata":null,"created_at":"2026-07-19T02:53:04.088079Z","pmid":"40168074","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}